[1] 中华人民共和国国家卫生健康委员会.新型冠状病毒感染的肺炎诊疗方案[EB/OL].
[2] HUANG C, WANG Y, LI X, et al.Clinicalfeatures of patients infected with 2019 novel coronavirus in Wuhan, China[J].Lancet, 2020, 395(10223):497. doi: 10.1016/S0140-6736(20)30183-5
[3] WANG D, HU B, HU C, et al.Clinical characteristics of 138 hospitalized patients with 2019 Novel Coronavirus-infected pneumonia in Wuhan, China[J].JAMA, 2020.DOI:10.1001/jama.2020.1585.
[4] CHAN JF, YUAN S, KOK KH, et al.A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission:a study of a family cluster[J].Lancet, 2020, 395(10223):514. doi: 10.1016/S0140-6736(20)30154-9
[5] REN LL, WANG YM, WU ZQ, et al.Identification of a novel coronavirus causing severe pneumonia in human:a descriptive study[J].Chinese Med J, 2020.DOI:10.1097/CM9.0000000000000722.
[6] CHEN Y, LIU Q, GUO D, et al.Emerging coronaviruses:Genome structure, replication, and pathogenesis[J].J Med Virol, 2020, 92(4):418. doi: 10.1002/jmv.25681
[7] GRALINSKI LE, MENACHERY VD.Return of the Coronavirus:2019-nCoV[J].Viruses, 202012(2).DOI:10.3390/v12020135.
[8] 华中科技大学同济医学院附属同济医院救治医疗专家组.新型冠状病毒感染的肺炎诊疗快速指南(第三版)(EB/OL).https://www.tjh.com.cn/html/2020/0128/28713.shtml#title.[2020-1-28].
[9] BENVENUTO D, GIOVANNETTI M, CICCOZZI A, et al.The 2019-new coronavirus epidemic:evidence for virus evolution[J].J Med Virol, 2020.DOI:10.1002/jmv.25688.
[10] LI Q, GUAN X, WU P, et al.Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia[J].N Engl J Med, 2020.DOI:10.1056/NEJMoa2001316.
[11] GUO L, WEI D, ZHANG X, et al.Clinical features predicting mortality risk in patients with viral pneumonia:the MuLBSTA score[J].Front Microbiol, 2019, 10:2752. doi: 10.3389/fmicb.2019.02752
[12] 陈蕾, 刘辉国, 刘威, 等.2019新型冠状病毒肺炎29例临床特征分析[J].中华结核和呼吸杂志, 2020, 43(3):203. doi: 10.3760/cma.j.issn.1001-0939.2020.03.013
[13] CASTRUCCI MR.Factors affecting immune responses to the influenza vaccine[J].Hum Vaccin Immunother, 2018, 14(3):637.
[14] LA GRUTA NL, KEDZIERSKA K, STAMBAS J, et al.A question of self-preservation:immunopathology in influenza virus infection[J].Immunol Cell Biol, 2007, 85(2):85. doi: 10.1038/sj.icb.7100026
[15] YANG PH, ING YB, XU Z et al.Epidemiological and clinical features of COVID-19 patients with and without pneumonia in Beijing, China[J].Medrxiv, 2020.DOI:10.1101/2020.02.28.20028068